ClinicalTrials.gg
RecruitingNCT06039787acExUpdated Nov 8, 2023

Exercise Training on Brain Insulin Responsiveness

An interventional study of single bout of moderate intensity continuous training (MICT) and single bout of High Intensity Interval Training (HIIT) in Insulin Resistance and Obesity, sponsored by University Hospital Tuebingen. Recruiting at 1 site in Germany. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-08.

Sponsored by University Hospital Tuebingen · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Insulin Resistance by University Hospital Tuebingen — 4 open to participants now, 6 under way, none of them phase 3. Insulin Resistance · University Hospital Tuebingen.

Planned enrollment
6th of 16
40 · median 35
Started
2023
the only one that year
No phase
16 of 19
3 open now
Registered
18th of 19
by date

Among the 19 studies in Insulin Resistance by University Hospital Tuebingen, this one is the 6th largest by planned enrollment of the 16 interventional ones that give a count, is the only one that started in 2023, is one of 16 with no phase, and was the 18th registered.

Insulin Resistance

2,974 studies on the registry are indexed under Insulin Resistance; 336 are open to participants now.

Browse Insulin Resistance studies →

Open to participants now

4 of the 19 studies in Insulin Resistance by University Hospital Tuebingen are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 241 Insulin Resistance studies recruiting now, 52 (22%) set no upper age limit and 157 (65%) stop at 75 or younger; 28 take children under 18; 112 take healthy volunteers.

This study: 20 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Insulin Resistance by University Hospital Tuebingen, or all of them as a file.
02

Study summary

The overarching goal of the current study is to investigate the effect of one acute bout of exercise on the brain insulin responsiveness in a cross-over study design. To this end, investigators will compare the effect of two single endurance exercise sessions with different intensities, namely moderate intensity continuous training (MICT) and high-intensity-interval-training (HIIT), which will be performed in a randomized order. This will be compared to a waiting control condition.

Read the detailed description

Investigate one acute bout of exercise on the brain insulin responsiveness using functional magnetic resonance imaging in combination with intranasal insulin in healthy participants of normal-weight and overweight/obesity. Two single endurance exercise sessions with different intensities will be evaluated, namely moderate intensity continuous training (MICT) and high-intensity interval training (HIIT). This will be compared to a waiting control condition. In a cross-over design, investigators will compare cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT compared to a control condition without exercise. Cerebral response is defined as the cerebral blood flow and resting state functional connectivity in response to intranasal insulin. Secondary outcomes include changes in blood metabolites and proteins and changes in eating behavior.

03

Conditions studied

  • Insulin Resistance
  • Obesity

Keywords

  • Exercise
  • functional magnetic resonance imaging
  • Intranasal insulin
04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • between ≥ 19.5 to 39 kg/m2-
  • Less than 150 min/week for moderate-intensity physical activity
  • Less than 75 min/week for Vigorous- intensity exercise (WHO recommendations for regular physical activity of adults)
  • Written consent to participate in the study
  • Written consent to be informed about incidental findings

Exclusion criteria

Exclusion Criteria

  • Type 2 diabetes, cardiovascular diseases such as chronic heart failure, myocardial infarction, status post stroke
  • Limitations to participate in ergometer-based exercise (balance and coordination disorders, orthopedic problems, ...)
  • Insufficient knowledge of the German language
  • Persons who cannot legally give consent
  • Pregnancy or lactation
  • History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures and migraines)
  • Taking psychotropic drugs
  • Taking medications that influence glucose metabolism
  • Regular use of analgesic drugs
  • Taking anticoagulant agents
  • Previous bariatric surgery
  • Acute infection within the last 4 weeks
  • values less than 12g/dl for women, less than 14 g/dl for men
  • Other diseases that in the opinion of the investigator may jeopardize the success of the study or indicate a risk to the volunteer
  • Current participation in a lifestyle intervention study or a pharmaceutical study
  • Metal implants which cannot be removed as pacemakers, artificial heart valve, electrical devices as insulin pumps, large tattoos, retainer over more than 4 teeth, coil, implanted magnetic metal parts as screws or plates after a surgery
  • Persons with claustrophobia
  • Temperature-sensitive person
  • Persons with tinnitus or increased sensitivity to loud sounds
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    moderate intensity continuous training

    Behavioral: single bout of moderate intensity continuous training (MICT)

  • Experimental
    High-intensity interval training

    Behavioral: single bout of High Intensity Interval Training (HIIT)

  • Placebo comparator
    Waiting condition

    Behavioral: waiting control

Interventions

  • Behavioralsingle bout of moderate intensity continuous training (MICT)

    the MICT consists of 60 min continuous cycling

  • Behavioralsingle bout of High Intensity Interval Training (HIIT)

    HIIT consists of 10-min warm-up at the power output corresponding to 50% peak power output (PPO), 4 x 4-min intervals at a power output corresponding to 75% PPO with a 4-min active resting period at 30% PPO to recover

  • Behavioralwaiting control

    sitting in a waiting room for 60 min

06

What researchers measure

Primary outcomes

  1. Cerebral response after intranasal insulin administration

    The resting-state cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    Time frame: 1 hour after exercise or waiting control

Secondary outcomes

  1. Task based brain activation after high-intensity-interval-training (HITT) or moderate intensity continuous training (MICT) compared to control condition

    Food cue reactivity after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    Time frame: 1 hour after exercise or waiting control

  2. Subjective feeling of hunger and food craving

    Questionnaire assessment before and after exercise or waiting control.

    Time frame: baseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

  3. Changes in Blood-brain barrier integrity

    Robust multiple echo-time arterial spin labelling based Blood Brain Barrier integrity measurements from before to after intranasal insulin administration after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    Time frame: 1 hour after exercise or waiting control

  4. Performance during cognitive tasks

    Cambridge Cognition Tests Battery to assess memory and inhibitory control using the paired associates learning task, the pattern recognition memory task and the stop-signal reaction task.

    Time frame: 1 hour after exercise or waiting control

  5. Changes in exerkines from plasma samples

    Blood sampling at 5 time points before and after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    Time frame: baseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

  6. Change in incretins from plasma samples

    Blood sampling at 5 time points before and after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    Time frame: baseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.

Of 715 non-industry interventional studies with no phase under Insulin Resistance, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 38 months is above that.

Counting every sponsor, half of 755 studies reached it within 21 months; a quarter within 9 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2023
First posted
Sep 15, 2023
StartActual
Oct 20, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 8, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06039787
Responsible party
Sponsor
First posted
Sep 15, 2023
Start date
Oct 20, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 8, 2023

Study contacts

Stephanie Kullmann, PhD
Contact
stephanie.kullmann@med.uni-tuebingen.de
0049707129 ext. 87703
Andreas L. Birkenfeld, MD
study director · Institute for Diabetes research and Metabolic Diseases at the University of Tubingen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion